Francesco Impagnatiello

Francesco Impagnatiello

UNVERIFIED PROFILE

Are you Francesco Impagnatiello?   Register this Author

Register author
Francesco Impagnatiello

Francesco Impagnatiello

Publications by authors named "Francesco Impagnatiello"

Are you Francesco Impagnatiello?   Register this Author

22Publications

360Reads

18Profile Views

New furoxan derivatives for the treatment of ocular hypertension.

Bioorg Med Chem Lett 2017 02 18;27(3):479-483. Epub 2016 Dec 18.

Dipartimento di Scienza e Tecnologia del Farmaco - Università degli Studi di Torino, Via P. Giuria 9, 10125 Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2016.12.041DOI Listing
February 2017

Repeated Dosing with NCX1404, a Nitric Oxide-Donating Pregabalin, Re-establishes Normal Nociceptive Responses in Mice with Streptozotocin-Induced Painful Diabetic Neuropathy.

J Pharmacol Exp Ther 2016 May 23;357(2):240-7. Epub 2016 Feb 23.

Department of Medical Sciences, Pharmacology Section, University of Ferrara, Ferrara, Italy (K.V., F.V., M.T., A.R.); Nicox Research Institute, Bresso, Milano, Italy (E.B., L.S., S.B., N.A., F.I.)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1124/jpet.115.230193DOI Listing
May 2016

Nitric oxide (NO): an emerging target for the treatment of glaucoma.

Invest Ophthalmol Vis Sci 2014 Aug 14;55(8):5005-15. Epub 2014 Aug 14.

Nicox Research Institute, Bresso, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1167/iovs.14-14515DOI Listing
August 2014

A new approach to antiglaucoma drugs: carbonic anhydrase inhibitors with or without NO donating moieties. Mechanism of action and preliminary pharmacology.

J Enzyme Inhib Med Chem 2012 Feb 4;27(1):138-47. Epub 2011 Aug 4.

Università degli Studi di Firenze, Department of Preclinical and Clinical Pharmacology, Florence, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/14756366.2011.597749DOI Listing
February 2012

Switching the microglial harmful phenotype promotes lifelong restoration of subtantia nigra dopaminergic neurons from inflammatory neurodegeneration in aged mice.

Rejuvenation Res 2011 Aug 27;14(4):411-24. Epub 2011 Jul 27.

OASI Institute for Research and Care on Mental Retardation and Brain Aging, Neuropharmacology Section, Troina, Italy .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/rej.2010.1134DOI Listing
August 2011

Imidazenil: a low efficacy agonist at alpha1- but high efficacy at alpha5-GABAA receptors fail to show anticonvulsant cross tolerance to diazepam or zolpidem.

Neuropharmacology 2008 Aug 9;55(2):148-53. Epub 2008 May 9.

The Psychiatric Institute, Department of Psychiatry, College of Medicine, University of Illinois, 1601 W. Taylor St., Chicago, IL 60612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neuropharm.2008.05.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2601598PMC
August 2008

NCX 6560, a nitric oxide-releasing derivative of atorvastatin, inhibits cholesterol biosynthesis and shows anti-inflammatory and anti-thrombotic properties.

Eur J Pharmacol 2007 Sep 5;570(1-3):115-24. Epub 2007 Jun 5.

Department of Internal Medicine, Division of Internal and Cardiovascular Medicine, University of Perugia, Perugia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejphar.2007.05.014DOI Listing
September 2007

Persistent behavioral sensitization to chronic L-DOPA requires A2A adenosine receptors.

J Neurosci 2002 Feb;22(3):1054-62

Molecular Neurobiology Laboratory, Massachusetts General Hospital, Boston, Massachusetts 02129, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6758487PMC
February 2002